Delivery Order SPE2DB22D2214-SPE2DB25FS6NC
- Not listed
- The Defense Logistics Agency awarded a $141,400 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Bepotastine 1.5% eye drops. Under this contract, Amerisourcebergen will provide approximately 5 milliliters of the ophthalmic solution to support the Defense Logistics Agency's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in September 2023. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a delivery order valued at $2,880.44 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3mL) on August 19, 2025, with completion expected by August 20, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $5,957.57 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,261.74 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml) on September 11, 2025, with an ultimate completion date of September 12, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $14,193.62 to AmerisourceBergen Drug Corp for MIEBO 100% Eye Drop (3ml) on August 12, 2025, with completion scheduled for August 13, 2025. This firm fixed-price delivery order carries no set-aside designation and reflects a competitive award to the prime contractor. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and operates as a...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $2,555.92 delivery order from the Defense Logistics Agency (DLA) on August 7, 2025, for MIEBO 100% eye drop solution in 3 milliliter quantities. This is a non-set-aside, competitively awarded contract utilizing firm fixed pricing under a child delivery order mechanism. The place of performance is the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August...
- The Defense Logistics Agency awarded a delivery order valued at $8,490.73 to AmerisourceBergen Drug Corp on September 4, 2025, for MIEBO 100% eye drop solution in 3ml quantities. The contract is a firm fixed price delivery order with performance in Conshohocken, Pennsylvania, and an ultimate completion date of September 5, 2025. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability to compete for federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a $5,322.00 delivery order to AmerisourceBergen Drug Corp for Miebo 100% eye drop (3ml) on September 3, 2025, with completion by September 4, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $5,536.60 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ML) on September 9, 2025, with a completion date of September 10, 2025. This is a firm fixed price, non-set-aside contract awarded through open competition. The award represents a small-value delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a ceiling value of $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $8,723.79 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ML units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS6NCDelivery Order
The Defense Logistics Agency awarded a $7,604.65 delivery order to AmerisourceBergen Drug Corp for the supply of Bepotastine 1.5% eye drops (10mL) on September 11, 2025, with completion scheduled for September 12, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The SPE2DX contract serves as a global pharmaceutical support vehicle enabling the company to supply a comprehensive range of medications, vaccines, and medical supplies to support military healthcare systems worldwide. AmerisourceBergen's federal contracting demonstrates consistent capability to fulfill competitive federal medical supply requirements across multiple therapeutic domains, supporting organizations including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 9/11/25 |